Alvotech executives to speak at Morgan Stanley Global Healthcare Conference fireside chatPUBT·Aug 27 at 07:01 AMALVO+1.43%MS-0.04%
Alvotech (NASDAQ:ALVO) Shares Gap Up - What's Next?Market Beat·Aug 24 at 10:00 AMALVO+1.43%GS-A-0.26%
Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On Mondaybenzinga_article·Aug 24 at 09:22 AMALVO+1.43%RUMBW-12.57%
Why Alvotech (ALVO) Is Up 9.2% After $150 Million Lotus Biosimilar Deal And 2026 UpdateSimplywall·Aug 22 at 02:39 AMALVO+1.43%
Weekly Recap | Alvotech SA +9.25%, full-year guidance reaffirmedWeekly Review·Aug 22 at 01:55 AMALVO+1.43%
Alvotech (NASDAQ:ALVO) Sees Strong Trading Volume - What's Next?Market Beat·Aug 21 at 01:00 PMALVO+1.43%GS-0.66%
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets | ALVO Stock NewsStockTitan·Aug 21 at 12:00 AMALVO+1.43%
Alvotech (ALVO) Stock Rises On Guidance Resolve Despite Lingering Loss RiskSimplywall·Aug 20 at 06:40 PMALVO+1.43%
ALVO: Revenue and EBITDA fell in H1 2026, but outlook is strong as manufacturing recoversQuartr·Aug 19 at 03:37 PMALVO+1.43%
Alvotech (NASDAQ:ALVO) Releases Earnings Results, Misses Estimates By $0.17 EPSMarket Beat·Aug 19 at 03:56 PMALVO+1.43%
